Hill-Rom Holdings ROE 2006-2018 | HRC

Current and historical return on equity (ROE) values for Hill-Rom Holdings (HRC) over the last 10 years.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.003B $2.744B
HILL-ROM HOLDINGS, Inc. traces its roots back to 1929 when William A. Hillenbrand formed the company as a division of Hillenbrand Industries. At that time, the company was focused on developing innovative beds and furnishings for hospital patient rooms. Now, after nearly eighty years, Hill-Rom leads the way as an innovator in the medical technology field developing solutions that enhance outcomes for patients and their caregivers.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $119.518B 18.50
Abbott Laboratories (ABT) United States $111.818B 23.45
Stryker (SYK) United States $64.600B 25.84
Boston Scientific (BSX) United States $46.527B 25.94
Baxter (BAX) United States $40.022B 28.64
Zimmer Biomet Holdings (ZBH) United States $22.815B 14.37
ResMed (RMD) United States $15.531B 32.48
Smith & Nephew SNATS (SNN) United Kingdom $15.356B 0.00
Perrigo (PRGO) Ireland $10.500B 14.72
Bio-Rad Laboratories (BIO) United States $9.132B 73.65
ICU Medical (ICUI) United States $6.169B 57.40
Canopy Growth (CGC) Canada $5.511B 0.00
Agios Pharmaceuticals (AGIO) United States $5.252B 0.00
Insulet (PODD) United States $5.222B 0.00
Haemonetics (HAE) United States $5.160B 53.14
Hutchison China MediTech (HCM) China $4.366B 0.00
Neogen (NEOG) United States $4.219B 67.46
GW Pharmaceuticals (GWPH) United Kingdom $4.127B 0.00
National Vision Holdings (EYE) United States $3.044B 0.00
NuVasive (NUVA) United States $2.767B 27.97
Quidel (QDEL) United States $2.615B 114.44
Abaxis,Inc (ABAX) United States $1.905B 64.07
Phibro Animal Health (PAHC) United States $1.899B 28.20
NxStage Medical (NXTM) United States $1.821B 0.00
VAREX IMAGING (VREX) United States $1.447B 22.29
Eagle Pharmaceuticals (EGRX) United States $1.244B 34.80
Cardiovascular Systems (CSII) United States $1.184B 0.00
Orthofix (OFIX) $1.110B 33.82
Owens & Minor (OMI) United States $1.080B 10.86
OraSure Technologies (OSUR) United States $1.033B 62.63
AtriCure (ATRC) United States $1.027B 0.00
Cerus (CERS) United States $0.973B 0.00
Omeros (OMER) United States $0.968B 0.00
TG Therapeutics (TGTX) United States $0.952B 0.00
MacroGenics (MGNX) United States $0.938B 0.00
Surmodics (SRDX) United States $0.799B 136.93
LeMaitre Vascular (LMAT) United States $0.713B 41.96
Meridian Bioscience (VIVO) United States $0.671B 23.66
PetIQ (PETQ) United States $0.647B 0.00
Insys Therapeutics (INSY) United States $0.612B 0.00
Lantheus Holdings (LNTH) United States $0.530B 13.85
Evolus (EOLS) United States $0.467B 0.00
Surface Oncology (SURF) United States $0.402B 0.00
Utah Medical Products (UTMD) United States $0.363B 24.05
Cytosorbents (CTSO) United States $0.360B 0.00
Quanterix (QTRX) United States $0.346B 0.00
NanoString Technologies (NSTG) United States $0.321B 0.00
BioLife Solutions (BLFS) United States $0.299B 0.00
Rockwell Medical (RMTI) United States $0.235B 0.00
Chimerix (CMRX) United States $0.220B 0.00
Bovie Medical (BVX) United States $0.171B 0.00
Fonar (FONR) United States $0.169B 10.23
Chembio Diagnostics (CEMI) United States $0.157B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.130B 0.00
Female Health (VERU) United States $0.110B 0.00
Trinity Biotech (TRIB) Ireland $0.104B 31.00
Oramed Pharmaceuticals (ORMP) Israel $0.095B 0.00
United-Guardian (UG) United States $0.088B 20.48
Neurotrope (NTRP) United States $0.081B 0.00
InfuSystems Holdings (INFU) United States $0.075B 0.00
CAS Medical Systems (CASM) United States $0.055B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.049B 0.00
Capricor Therapeutics (CAPR) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Valeritas Holdings (VLRX) United States $0.036B 0.00
Akers Biosciences Inc (AKER) United States $0.035B 0.00
Myomo (MYO) United States $0.033B 0.00
Senestech (SNES) United States $0.026B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.003B 0.00